期刊文献+

RP-HPLC测定人血浆中洛伐他汀浓度及药动学研究 被引量:12

Determination of Lovastatin in Human Plasma by RPHPLC and Its Pharmacokinetics Study
暂未订购
导出
摘要 用RP-HPLC测定人血浆中洛伐他汀浓度。以甲醇-水(83∶17,V/V)为流动相,色谱柱采用HYPERSILBDS-C18(5μm)不锈钢柱,紫外237nm波长检测。血浆样品经环己烷-异丙醇(95∶5)萃取浓缩后进样测定。洛伐他汀浓度在2.5~80ng/ml范围内线性良好,r=0.9968。测定含洛伐他汀20.0ng/ml的血浆样品,其日内(n=7)及日间(n=7)的RSD分别为9.8%和8.5%。回收率平均为(101.3±5.5)%。测定了10名健康志愿者单次po洛伐他汀片剂80mg后不同时间的血药浓度,计算了相应的药动学参数。 A simple and rapid RP HPLC method has been developed for determining lovastatin in human plasma. The analytical column was packed with HYPERSIL BDS. The mobile phase was methanol water(83∶17, V/V ). The lovastatin in plasma sample was extracted by cyclohexane isopropyl alcohol(95∶5). The compounds were quantitated using a ultraviolet detector operated at 237 nm which allowed determination of 2.5 ̄80 ng/ml of lovastatin with reproducibility. The limit of detection was 1 ng/ml. Intra day and inter day RSD for assaying the plasma sample containing 20 ng/ml concentration of lovastatin were 9.8%( n =7) and 8.5%( n = 7), respectively. The mean recovery was 101. 7%. The pharmacokinetics of lovastatin in ten healthy volunteers after oral administration of 80 mg was studied.
出处 《中国药科大学学报》 CAS CSCD 北大核心 1997年第5期288-290,共3页 Journal of China Pharmaceutical University
关键词 洛伐他汀 药代动力学 血药浓度 降血脂药 HPLC Lovastatin RP HPLC Pharmacokinetics Plasma concentration
  • 相关文献

同被引文献76

  • 1何璧梅,姚国柱,张辉,徐寅正,隆泉.血脂调节剂的研究——Ⅰ.HMG-CoA还原酶抑制剂M-8614A及MH-2688B产生菌的筛选[J].中国抗生素杂志,1993,18(2):136-139. 被引量:12
  • 2郁韵秋,黄建明,翁伟宇,顾丽华,王以俭,张莉.高效液相色谱-质谱联用法测定人血浆中洛伐他汀的浓度[J].中国新药与临床杂志,2005,24(12):954-957. 被引量:2
  • 3张哲峰,鹿颐,王元度,梁贵键.RP—HPLC法分离测定洛伐他汀及其杂质[J].药物分析杂志,1996,16(6):373-376. 被引量:4
  • 4黄先勇,盖鲁粤,王思让,吴旭辉,向定成,贺书兰,栗瑞福,石怀银.中国小型猪动脉粥样硬化狭窄模型的建立及其意义[J].实验动物科学与管理,1997,14(1):29-32. 被引量:8
  • 5Xiao H,Shen H,Chen JF.Determination of Lovastatin leverl in human plasma and Lovastatin capsules bioaviailability of healthy volunteers using HPLC-MS.Journal of Chinese Pharmaceutical Sciences,2006;15(4):233-237.
  • 6Lodge JW,Fletcher BL,Brown SS.Determination of lovastatin hydroxy acid in female B6C3F1 mouse serum.Journal of Analytical Toxicology,2008;32(3):248-252.
  • 7Wu YH,Jamie Z,Janck H,et al.Microsample determination of Lovastatin and its hydroxy acid metabolite in mouse and rat plasma by liquid chromatography/ionspray tandem mass spectrometry.Journal of Mass Spectrometry,1997;32(4):379-387.
  • 8Pearson TA, Mart HJ. The rapid reduction in cardiac events with lipip lowering therapy:mechanisms and implication[J]. Am J Cardial, 1993, 72 : 1072 - 1073.
  • 9Holme I. An analysis of randomized trials evaluating; the effect of cholesterol reduction on total mortality and coronary heart disease indicence[J]. Circulation, 1990, 82:1916 - 1924.
  • 10Bilheime DW. Therapeutic control of hyperlipidemia in the prevention of coronary atherosclerosis: A review of resultls from recent clinical trails[J]. Am J Cardiol, 1988, 62 : 1 - 9.

引证文献12

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部